This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hadasit Medical Research Services and Development Ltd.. Active years: 2019-2022.
Company Filing History:
Years Active: 2019-2022
Title: Ronny Uzana: Innovator in Cancer Therapy
Introduction
Ronny Uzana is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of immunotherapy, particularly in cancer treatment. With a total of 2 patents, his work focuses on innovative methods that enhance T cell modulation for improved patient outcomes.
Latest Patents
Ronny Uzana's latest patents include groundbreaking inventions aimed at cancer therapy. The first patent, titled "Methods for cancer therapy using isolated NTB-A ectodomain polypeptides," is directed towards immunotherapy. This invention provides compositions and methods for improved T cell modulation both ex vivo and in vivo, specifically targeting cancer and other pathologies. The use of soluble NTB-A polypeptides or agonists is emphasized for treating cancer patients and preventing cytopenia in susceptible individuals.
The second patent, "Cell compositions and methods for cancer therapy," also focuses on immunotherapy. It outlines similar methodologies for enhancing T cell modulation and treatment of cancer. The emphasis remains on the use of soluble NTB-A polypeptides or agonists for effective patient care.
Career Highlights
Ronny Uzana is associated with Hadasit Medical Research Services and Development Ltd., where he continues to advance his research in cancer therapy. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic methods.
Collaborations
Ronny collaborates with esteemed colleagues, including Abraham Rutenberg and Michal Lotem. Their combined expertise contributes to the development of effective cancer therapies.
Conclusion
Ronny Uzana stands out as an influential inventor in the field of cancer therapy, with a focus on immunotherapy and T cell modulation. His contributions are paving the way for advancements in treatment options for cancer patients.